Pdt approvalHealth Canada approval 1993: Whole-bladder PDT (with hematoporphyrin derivative [Photofrin® ] I.V. ) for patients with recurring superficial papillary bladder cancer who have failed standard intravesical therapy. However, one Photofrin mediated PDT can be as effective as multiple BCG treatments.